Two Deaths Reported to Drug Safety Watchdog Over Possible Link to Weight-Loss Injections

Health authorities have confirmed that two deaths have been reported to the UK’s medicines safety watchdog amid concerns they may be linked to the growing use of weight-loss injections.

The reports were submitted to the Medicines and Healthcare products Regulatory Agency (MHRA), the body responsible for monitoring the safety of medicines and medical products across the UK.

Officials stressed that the deaths are currently being reviewed and that a direct causal link between the medications and the fatalities has not yet been established.

However, the reports have prompted renewed attention on the rapid rise in the use of injectable weight-loss treatments such as Wegovy and Ozempic, which have surged in popularity in recent years.

Originally developed as treatments for Type 2 Diabetes, these medications have also been approved in certain cases for weight management because they can significantly reduce appetite and slow digestion.

The drugs work by mimicking a hormone known as GLP-1, which helps regulate blood sugar levels and signals to the brain that the body feels full.

In recent months, demand for the injections has exploded, driven by growing public awareness, celebrity endorsements, and widespread discussion on social media.

However, the surge in popularity has also raised concerns among regulators and medical professionals about misuse, supply shortages, and potential side effects.

The MHRA operates a monitoring system known as the Yellow Card Scheme, which allows doctors, pharmacists and members of the public to report suspected side effects from medicines.

Officials say the two deaths were reported through this system and are now undergoing detailed review.

Importantly, a report through the scheme does not mean the medication caused the death, only that a possible link has been flagged and requires investigation.

Medical experts say that, like all medications, weight-loss injections can cause side effects in some patients. These may include nausea, vomiting, digestive issues and in rare cases more serious complications.

Doctors have warned that the medications should only be used under proper medical supervision, particularly for individuals with underlying health conditions.

The issue has also drawn attention to the growing online market for weight-loss drugs, where some injections are being sold through unregulated websites or social media platforms.

Regulators have repeatedly warned that purchasing prescription medicines from unofficial sources carries serious risks, including the possibility of counterfeit or unsafe products.

Despite the reports now under investigation, health authorities say millions of people worldwide are using the medications safely under medical supervision.

The MHRA says it will continue monitoring the situation closely and reviewing all available evidence as part of its ongoing safety assessment.

For now, officials are urging patients not to stop taking prescribed medication without speaking to their doctor, but to seek medical advice if they experience concerning symptoms.

As the popularity of weight-loss injections continues to grow, regulators say careful monitoring will remain essential to ensure the medicines are used safely and appropriately.